1-11 of 11
Authors: Leonardo De Luca
Journal Article
Cost–effectiveness of ticagrelor in patients with type 2 diabetes and coronary artery disease: a European economic evaluation of the THEMIS trial
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 8, December 2022, Pages 777–785, https://doi.org/10.1093/ehjcvp/pvac032
Published: 30 April 2022
Journal Article
Pre-treatment with dual antiplatelet therapy in non-ST-segment elevation acute coronary syndromes: landing from guidelines recommendations to real-world ground
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 5, September 2021, Pages 442–444, https://doi.org/10.1093/ehjcvp/pvab045
Published: 15 June 2021
Journal Article
Unravelling the puzzle of antithrombotic therapies for complex percutaneous coronary intervention
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 4, July 2021, Pages 352–359, https://doi.org/10.1093/ehjcvp/pvaa107
Published: 16 September 2020
Journal Article
Combinations of antithrombotic therapies prescribed after percutaneous coronary intervention in patients with acute coronary syndromes and atrial fibrillation: data from the nationwide MATADOR-PCI registry
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages e45–e47, https://doi.org/10.1093/ehjcvp/pvaa088
Published: 11 July 2020
Journal Article
Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 2, March 2021, Pages 94–103, https://doi.org/10.1093/ehjcvp/pvaa002
Published: 22 January 2020
Journal Article
Is ticagrelor safe in octogenarian patients with non-ST elevation acute coronary syndromes?
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 4, Issue 1, January 2018, Pages 12–14, https://doi.org/10.1093/ehjcvp/pvx034
Published: 27 October 2017
Journal Article
Diabetic patients with acute coronary syndromes in contemporary European registries: characteristics and outcomes
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 3, Issue 4, October 2017, Pages 198–213, https://doi.org/10.1093/ehjcvp/pvw049
Published: 10 March 2017
Journal Article
P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 4, October 2016, Pages 229–243, https://doi.org/10.1093/ehjcvp/pvw005
Published: 03 March 2016
Journal Article
Use, patient selection and outcomes of P2Y12 receptor inhibitor treatment in patients with STEMI based on contemporary European registries
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 2, Issue 3, July 2016, Pages 152–167, https://doi.org/10.1093/ehjcvp/pvw003
Published: 27 January 2016
Journal Article
Contemporary registries on P2Y12 inhibitors in patients with acute coronary syndromes in Europe: overview and methodological considerations
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 1, Issue 4, October 2015, Pages 232–244, https://doi.org/10.1093/ehjcvp/pvv024
Published: 12 May 2015
Journal Article
Contemporary antithrombotic strategies in patients with acute coronary syndromes managed without revascularization: insights from the EYESHOT study
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 1, Issue 3, July 2015, Pages 168–178, https://doi.org/10.1093/ehjcvp/pvv006
Published: 25 February 2015
